Skip to main content

Table 1 The antinuclear antibodies indexes of two SLE patients at different time points

From: Short-term assessment of BCR repertoires of SLE patients after high dose glucocorticoid therapy with high-throughput sequencing

Antinuclear antibodies

P1

P2

Anti-nRNP/SM

3+, 2+, 2+

3+, 2+, 1+

Anti-SM

N, N, N

2+, 1+, N

Anti-SSA

3+, 3+, 3+

3+, 3+, 3+

Anti-RO-52

N, N, N

3+, 3+, 3+

Anti-SSB

N, N, N

1+, N, N

Anti-SCOL-70

N, N, N

N, N, N

Anti-JO-1

N, N, N

N, N, N

Anti-CENP B

N, N, N

N, N, N

Anti-dsDNA

3+, 2+, 2+

1+, N, N

Anti-nucleosome

3+, 3+, 3+

N, N, N

Anti-histone

3+, 1+, 1+

N, N, N

Anti-ribosomal P

N, N, N

3+, 3+, 2+

ACA

N, N, N

N, N, N

  1. The “N” represents negative result, the “1+” represents weakly positive result, “2+” represents positive result, “3+” represents strong positive result